Manuscripts
Showing 1569 manuscripts.
Safety and pharmacokinetics of lopinavir/ritonavir oral solution in preterm and term infants starting before 3 months of age
Citation
Adrie Bekker, Jincheng Yang, Jiajia Wang, Mark F. Cotton, Mae Cababasay, Lubbe Wiesner, Jack Moye, Renee Browning, Firdose L. Nakwa, Helena Rabie, Avy Violari, Mark Mirochnick, Tim. R Cressey, Edmund V. Capparelli. Safety and pharmacokinetics of lopinavir/ritonavir oral solution in preterm and term infants starting before 3 months of age. Pediatric Infectious Disease Journal. 2024. 43: 355-360. PMID: 38190642Year
2024
Journal
Pediatric Infectious Disease Journal
Study
P1106
Safety and pharmacokinetics of oral and long-acting
injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre,
open-label, non-comparative, dose-finding st
Citation
Aditya H. Gaur, Edmund V. Capparelli, Katherine Calabrese, Kristin Baltrusaitis, Mark A Marzinke, Cynthia McCoig, Rodica M. Van Solingen-Ristea, Sisinyana Ruth Mathiba, Adeola Adeyeye, John H. Moye, Barbara Heckman, Elizabeth D. Lowenthal, Shawn Ward, Ryan Milligan, Pearl Samson, Brookie M. Best, Conn M. Harrington, Susan L. Ford, Jenny Huang, Herta Crauwels, Kati Vandermeulen, Allison L. Agwu, Christiana Smith-Anderson, Andres Camacho-Gonzalez, Pradthana Ounchanum, Jared L. Kneebone, Ellen Townley, Carolyn Bolton Moore, IMPAACT 2017 Team. Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2024. 11: e211-e221. PMID: 38538160Year
2024
Journal
Lancet HIV
Study
IMPAACT 2017
Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV
Citation
Betsy D. Kennard, Larry K. Brown, Kristin Baltrusaitis, Miriam Chernoff, Graham J. Emslie, Jessica Jones, Sarah Buisson, Jaime Deville, Megan Wilkins, Amber Bunch, Chivon McMullen Jackson, Christy Beneri, David E. Shapiro, IMPAACT 2002 Team. Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV. Cognitive Therapy and Research. 2024. 48: 781-790. PMID: 39664885Year
2024
Journal
Cognitive Therapy and Research
Study
IMPAACT 2002
Maternal immunity shapes biomarkers of germinal center development in HIV-exposed uninfected infants
Citation
John W. Sleasman, Guglielmo M. Venturi, Bernard M. Fischer, Julie J. Kim-Chang, Richard Barfield, Cliburn Chan, Kristina De Paris, Li Yin, Maureen M. Goodenow. Maternal immunity shapes biomarkers of germinal center development in HIV-exposed uninfected infants. Frontiers in Immunology. 2024. 15: 1443886. PMID: 39328414Year
2024
Journal
Frontiers in Immunology
Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life
Citation
Deborah Persaud, Ellen G. Chadwick, Jennifer Jao, IMPAACT P1115 Team, Mark F. Cotton, Yvonne Bryson, Anne Coletti, Theodore D. Ruel, Stephen A. Spector, Christina Reding, Kira Bacon, Diane Costello, Charlotte Perlowski, Maria Leticia Santos Cruz, Josphat Kosgei, Sai Majji, Bryan S. Nelson, Dwight E. Yin, Camlin Tierney, Patrick Jean-Philippe. Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life. Clinical Infectious Diseases. 2023. 76: e744-e747. PMID: 36031390Year
2023
Journal
Clinical Infectious Diseases
Study
P1115
Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014
Citation
Hong Wan, Hedy Teppler, Kathryn P Gray, Ellen Townley, Mounika Yedla, Jack Moye, Brookie M. Best, Nicole H. Tobin, IMPAACT 2014 Study Team, Havilland Campbell, Katie McCarthy, Rachel Scheckter, Linda Aurpibul, Pradthana Ounchanum, Supattra Rungmaitree, Hassena Cassim, Elizabeth McFarland, Patricia Flynn, Ann J Melvin, Ellen Cooper, Ka Lai Yee, Chelsea Krotje. Pharmacokinetics, tolerability, and safety of doravirine and doravirine/lamivudine/tenofovir disoproxil fumarate fixed dose combination tablets in adolescents living with HIV: Week 24 results from IMPAACT 2014. Journal of AIDS. 2023. PMID: 36215957Year
2023
Journal
Journal of AIDS
Study
IMPAACT 2014
Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India
Citation
David E. Shapiro, Patience Atuhaire, Taha E Taha, Bonus Makanani, Lameck Chinula, Maxensia Owor, Dhayendre Moodley, Tsungai Chipato, Katie McCarthy, Patricia M. Flynn, Judith Currier, Mary Glenn Fowler, Amita Gupta, Nishi Suryavanshi, Neetal Nevrekar, Kevin Butler. Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India. Journal of the International AIDS Society. 2023. 92: 76-83. PMID: 36170749Year
2023
Journal
Journal of the International AIDS Society
Study
1077FF, 1077BF
Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19
Citation
Kristina Brooks, Brookie M Best, Diana F Clarke, Mark Mirochnick, John N van den Anker, Edmund V Capparelli, Jeremiah D Momper, Xiaomei Liu, André Dallmann. Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19. CPT: pharmacometrics & systems pharmacology. 2023. 12: 148-153. PMID: 36479969Year
2023
Journal
CPT: pharmacometrics & systems pharmacology
Study
IMPAACT 2032
Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial
Citation
James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Philippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 TB APPRISE study team, Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati. Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial. Journal of Acquired Immune Deficiency Syndromes. 2023. PMID: 36650479Year
2023
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1078
Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia
Citation
International Maternal Pediatric Adolescent AIDS Clinical Trial (IMPAACT) 1025 protocol team, Jean Rene Anderson, Deborah Kacanek, Yanling Huo, Kevin Psoter, Lisa R Yanek, Khalil Ghanem, Irina Burd, Anna Maya Powell, Deborah Persaud. Markers of intestinal immune activation and inflammation are not associated with preterm birth among women with low level HIV viremia. American Journal of Reproductive Immunology. 2023. PMID: 36680487Year
2023
Journal
American Journal of Reproductive Immunology
Study
P1025